Blog
RSS FeedPosted by Michael Wonder on 02 Apr 2020
Proposal to fund modified release pancreatic enzyme granules (Creon Micro)
2 April 2020 - PHARMAC is seeking feedback on a proposal to fund a new modified-release granule formulation of pancreatic ...
Posted by Michael Wonder on 01 Apr 2020
PHARMAC widens funding for lenalidomide for those with blood cancer
1 April 2020 - Emma Holden was devastated when she learned she had multiple myeloma. ...
Posted by Michael Wonder on 31 Mar 2020
COVID-19: cancer and rare disorder patients 'will die' if PHARMAC doesn't spend money on medicines
31 March 2020 - Those with cancer and rare medical conditions have asked the Prime Minister to relax PHARMAC's rules ...
Posted by Michael Wonder on 31 Mar 2020
New Zealand Pharmaceutical Schedule - 1 April 2020 update
1 April 2020 - The April 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Mar 2020
PHARMAC eases restrictions on cancer drugs during COVID-19 pandemic
31 March 2020 - PHARMAC will ease restrictions on at least nine cancer drugs, including Keytruda, for the treatment of advanced ...
Posted by Michael Wonder on 27 Mar 2020
Change to monthly dispensing
27 March 2020 - PHARMAC has changed Pharmaceutical Schedule rules that restrict the dispensing of funded community medicines to just one ...
Posted by Michael Wonder on 26 Mar 2020
PHARMAC places temporary dispensing limits on all funded community medicines
26 March 2020 - PHARMAC is placing temporary dispensing limits on all funded community medicines from Friday 27 March 2020. ...
Posted by Michael Wonder on 24 Mar 2020
COVID-19: sacubitril with valsartan (Entresto)
25 March 2020 - Sacubitril with valsartan is a medicine used in the management of clinically significant, treatment refractory heart ...
Posted by Michael Wonder on 24 Mar 2020
COVID-19: hydroxychloroquine
24 March 2020 - There has been a lot of interest around the use of hydroxychloroquine for treatment of COVID-19 ...
Posted by Michael Wonder on 20 Mar 2020
Decision to decline inactive medicines funding applications
20 March 2020 - To give people more clarity about what medicines PHARMAC is, or is not, actively considering for ...
Posted by Michael Wonder on 16 Mar 2020
Covid-19: medicine, vaccine supply disruptions likely - PHARMAC
16 March 2020 - Drug buying agency PHARMAC is warning further disruptions to medicine supplies are inevitable, as measures are taken ...
Posted by Michael Wonder on 13 Mar 2020
New drug: 'it's made a huge difference,' asthma sufferer says
12 March 2020 - Hundreds of severe asthma sufferers will have access to a new medicine from next month. ...
Posted by Michael Wonder on 12 Mar 2020
PHARMAC funds new medicine (mepolizumab) for severe asthma
12 March 2020 - Around 500 New Zealanders who have severe asthma will have access to a new medicine, mepolizumab, ...
Posted by Michael Wonder on 11 Mar 2020
Bowel cancer patient heartbroken she needs unfunded drug Keytruda to survive
11 March 2020 - A 26-year-old with stage four bowel cancer is heartbroken that funding is the only thing standing ...
Posted by Michael Wonder on 11 Mar 2020
Decision to widen funded access to lenalidomide for multiple myeloma
11 March 2020 - PHARMAC is pleased to announce a decision to widen funded access to lenalidomide (Revlimid) to include ...